Home / Health / Novo Nordisk Data Breach: Patient Info Copied
Novo Nordisk Data Breach: Patient Info Copied
15 Jun
Summary
- Novo Nordisk confirmed unauthorized external copying of patient data.
- Clinical trial information, not directly identifying patients, was affected.
- The company has taken IT systems offline and is investigating the incident.
Pharmaceutical giant Novo Nordisk announced on Thursday a significant security incident affecting its internal IT systems. The company confirmed that certain information, including patient data from some clinical trials, was copied externally without authorization.
The affected data is described as limited and not directly linked to patient names or other primary identifiers. Potential categories of personal data involved may include patient ID, year of birth, sex, and health or immunogenicity data. Novo Nordisk has stated that this information alone would not enable third parties to identify trial participants.
In response to the breach, Novo Nordisk has temporarily taken specific internal IT systems offline as a precautionary measure. The company is working with external cybersecurity experts to investigate the incident and restore systems safely. Core business operations remain unaffected and continue to run.
